The combined global market for tissue-engineered skin replacements and active wound repair modulators totaled more than $1bn in 2017, and is expected to climb at a rate of 6.0% over the next half-decade.

The tissue-engineered skin replacements segment accounts for nearly 90% of sales, with the 5EU markets, Japan, and the RoW markets combined accounting for the remaining 10% of sales.

The US accounts for nearly 92% of global sales in this market, due to factors including slower adoption of skin replacements in international markets as a result of cultural aversion to the use of cadaveric tissue, concerns regarding disease transmission, and limited reimbursement.

Key Questions Answered

What are the key drivers and limiters to the global wound care products market?

Which competitors are leading the market and introducing new technology?

How are technological advancements impacting market growth?

Which areas of the wound care products market are experiencing dynamic growth?

How are mergers and acquisitions affecting the markets shares of leading competitors?